382 related articles for article (PubMed ID: 30259246)
1. BMAL1 regulates balance of osteogenic-osteoclastic function of bone marrow mesenchymal stem cells in type 2 diabetes mellitus through the NF-κB pathway.
Li X; Liu N; Gu B; Hu W; Li Y; Guo B; Zhang D
Mol Biol Rep; 2018 Dec; 45(6):1691-1704. PubMed ID: 30259246
[TBL] [Abstract][Full Text] [Related]
2. Brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 cooperates with glycogen synthase kinase-3β to regulate osteogenesis of bone-marrow mesenchymal stem cells in type 2 diabetes.
Li X; Liu N; Wang Y; Liu J; Shi H; Qu Z; Du T; Guo B; Gu B
Mol Cell Endocrinol; 2017 Jan; 440():93-105. PubMed ID: 27717746
[TBL] [Abstract][Full Text] [Related]
3. Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.
Mao X; Li X; Hu W; Hao S; Yuan Y; Guan L; Guo B
Biol Open; 2020 Jul; 9(7):. PubMed ID: 32554484
[TBL] [Abstract][Full Text] [Related]
4. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappaB activation, osteoclastogenesis and bone resorption.
Wang L; Shi X; Zhao R; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
Bone; 2010 May; 46(5):1369-79. PubMed ID: 19962460
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
[TBL] [Abstract][Full Text] [Related]
7. Icariin promotes osteogenic differentiation of BMSCs by upregulating BMAL1 expression via BMP signaling.
Huang Z; Wei H; Wang X; Xiao J; Li Z; Xie Y; Hu Y; Li X; Wang Z; Zhang S
Mol Med Rep; 2020 Mar; 21(3):1590-1596. PubMed ID: 32016461
[TBL] [Abstract][Full Text] [Related]
8. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
9. Melatonin up-regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT
Zhou Y; Wang C; Si J; Wang B; Zhang D; Ding D; Zhang J; Wang H
Br J Pharmacol; 2020 May; 177(9):2106-2122. PubMed ID: 31900938
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
Wang F; Zhang C; Ge W; Zhang G
J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
[TBL] [Abstract][Full Text] [Related]
11. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
12. Canonical Wnt signaling is required for Panax notoginseng saponin-mediated attenuation of the RANKL/OPG ratio in bone marrow stromal cells during osteogenic differentiation.
Chen B; Li XD; Liu DX; Wang H; Xie P; Liu ZY; Hou GQ; Chang B; Du SX
Phytomedicine; 2012 Aug; 19(11):1029-34. PubMed ID: 22818895
[TBL] [Abstract][Full Text] [Related]
13. Bmal1- and Per2-mediated regulation of the osteogenic differentiation and proliferation of mouse bone marrow mesenchymal stem cells by modulating the Wnt/β-catenin pathway.
Zheng J; Zhang L; Tan Z; Zhao Q; Wei X; Yang Y; Li R
Mol Biol Rep; 2022 Jun; 49(6):4485-4501. PubMed ID: 35386071
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
15. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-31a-5p from aging BMSCs links bone formation and resorption in the aged bone marrow microenvironment.
Xu R; Shen X; Si Y; Fu Y; Zhu W; Xiao T; Fu Z; Zhang P; Cheng J; Jiang H
Aging Cell; 2018 Aug; 17(4):e12794. PubMed ID: 29896785
[TBL] [Abstract][Full Text] [Related]
17. The effects of α-zearalanol on the proliferation of bone-marrow-derived mesenchymal stem cells and their differentiation into osteoblasts.
Zong S; Zeng G; Fang Y; Peng J; Zou B; Gao T; Zhao J
J Bone Miner Metab; 2016 Mar; 34(2):151-60. PubMed ID: 25944420
[TBL] [Abstract][Full Text] [Related]
18. SIRT6 regulates osteogenic differentiation of rat bone marrow mesenchymal stem cells partially via suppressing the nuclear factor-κB signaling pathway.
Sun H; Wu Y; Fu D; Liu Y; Huang C
Stem Cells; 2014 Jul; 32(7):1943-55. PubMed ID: 24510807
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
